EUVIMEDEUVIMED entdecken
Crossref

Iron Oxide Nanoparticles for Hepatocyte-Targeted T2 Imaging with Inverse Illumination of Liver Tumors

Wang Qian, Ruiyang Suo, Yixin Liu, Zixun Zhang, Shuqi Li, Minghui Ma, Huan Ling, Jingjing Wang, Di Qiu, Jun Zhou, Bo Wu iD, Yongchang Wei

Analytical Chemistry · 2026

DOI: 10.1021/acs.analchem.6c00502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Chemistry, 2026. Verfasst von Wang Qian und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan430071, P. R. China. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Hepatocytes, Contrast Media, Liver Neoplasms. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Hubei Province, Fundamental Research Funds for the Central Universities, Zhongnan Hospital of Wuhan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatocellular carcinoma (HCC) remains one of the leading causes of cancer-related mortality worldwide, highlighting the urgent need for safe and effective imaging tools to improve early diagnosis. In this study, we developed a hepatocyte-targeted T2 MRI contrast agent by functionalizing superparamagnetic iron oxide nanoparticles (SPIONs) with an ethoxybenzyl-polyethylene glycol ligand, yielding Fe3O4-EOB-PEG2000 NPs, inspired by the hepatocyte-selective features of Gd-EOB-DTPA. In vitro studies demonstrated preferential uptake of Fe3O4-EOB-PEG2000 NPs by hepatocytes over tumor cells, while in vivo imaging in both hepatocellular carcinoma and colorectal liver metastasis models revealed a distinct “black-liver/bright-tumor” contrast effect. Compared with nontargeted Fe3O4-mPEG2000 NPs, Fe3O4-EOB-PEG2000 NPs showed significantly improved tumor visibility in T2-weighted images. Furthermore, Fe3O4-EOB-PEG2000 NPs exhibited good biocompatibility and biosafety. This work highlights a strategy for enhancing T2 MRI contrast through hepatocyte targeting, providing a promising gadolinium-free alternative for safe and effective safe and effective diagnosis of liver tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingHepatocytesContrast MediaLiver NeoplasmsMagnetic Iron Oxide NanoparticlesCarcinoma, HepatocellularFerric CompoundsAnimalsHumansPolyethylene GlycolsMice

Substanzen

Contrast MediaPolyethylene Glycolsferric oxideFerric Compounds

Autor:innen und Institutionen

  • Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan430071, P. R. China.
  • Department of Radiology, Zhongnan Hospital of Wuhan University, Wuhan430071, P. R. China.
  • Interventional Diagnostic and Therapeutic Center, Zhongnan Hospital of Wuhan University, Wuhan430071, P. R. China.

ORCID-Profile: Bo Wu

Förderung

  • Natural Science Foundation of Hubei Province
  • Fundamental Research Funds for the Central Universities
  • Zhongnan Hospital of Wuhan University
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Qian, W., Suo, R., Liu, Y., Zhang, Z., Li, S., Ma, M., Ling, H., Wang, J., Qiu, D., Zhou, J., Wu, B., & Wei, Y. (2026). Iron Oxide Nanoparticles for Hepatocyte-Targeted T2 Imaging with Inverse Illumination of Liver Tumors. Analytical Chemistry. https://doi.org/10.1021/acs.analchem.6c00502

Vancouver

Qian W, Suo R, Liu Y, Zhang Z, Li S, Ma M, et al. Iron Oxide Nanoparticles for Hepatocyte-Targeted T2 Imaging with Inverse Illumination of Liver Tumors. Analytical Chemistry. 2026. doi:10.1021/acs.analchem.6c00502

BibTeX
@article{Qian2026,
  author = {Qian, Wang and Suo, Ruiyang and Liu, Yixin and Zhang, Zixun and Li, Shuqi and Ma, Minghui and Ling, Huan and Wang, Jingjing and Qiu, Di and Zhou, Jun and Wu, Bo and Wei, Yongchang},
  title = {Iron Oxide Nanoparticles for Hepatocyte-Targeted T2 Imaging with Inverse Illumination of Liver Tumors},
  journal = {Analytical Chemistry},
  year = {2026},
  doi = {10.1021/acs.analchem.6c00502}
}
Kostenlos starten →